Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 370 participants.

Also called NCT05209412

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 370 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05209412
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05209412. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2024-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions
Acronym
CAGE-FREEIII
Condition
De Novo Stenosis
Intervention (Device)
Lepu Paclitaxel coated balloon
Intervention (Device)
Resolute Integrity Zotarolimus eluting stents
Intervention (Drug)
Aspirin
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Clopidogrel
Lead sponsor
Xijing Hospital (class: other)

Record details

Record id
cardio:ct-nct05209412
Content hash
fcdc328ef75a9ffbfb2dd20ae73946c30c400a54016036d3f50b6ec53f5e4e78